CompletedNCT00141050
Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD
This study has finished and is no longer accepting participants.
In HoustonADHDMedication studyAges 6–12
ADHD studies
ADHD
Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
CompletedNCT02895906
Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
What is this study about?
Researchers studied NFC-1, tracking side effects to assess safety in people with ADHD.
This study has finished and is no longer accepting participants.
In PhiladelphiaADHDMedication studyAges 12–17
CompletedNCT03318302
Sleep and Exposure to Screens of Digital Media Devices in Israel
Official study title
University of Haifa
This study has finished and is no longer accepting participants.
In HaifaADHDObservational studyAges 18+
CompletedNCT04647903
Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR)
Official study title
A Randomized, Double-Blind, Double-Dummy, Placebo-, Active-Controlled, 4 Period, 4 Way Crossover Study to Evaluate the Abuse Potential of Manipulated Abuse-Deterrent Dextroamphetamine Sulfate Immediate Release (ADAIR) Formulation Compared to Dextroamphetamine Sulfate Immediate Release When Administered Intranasally to Nondependent, Recreational Stimulant Users
This study has finished and is no longer accepting participants.
In Salt Lake CityADHDMedication studyAges 18–55
CompletedNCT01012375
Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.
Official study title
A Phase IIa, Multi-center, Randomized, Double-blind, Placebo-controlled, Cross-Over Study to Assess the Efficacy, Safety ,Tolerability and Pharmacokinetics of Three Oral AZD1446 Dose Regimens and Placebo During 2 Weeks of Treatment in Adult Non-Users and Users of Nicotine Containing Products
This study has finished and is no longer accepting participants.
Multiple locations, including Los AlamitosADHDMedication studyAges 18–65
CompletedNCT06698588
Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms
Official study title
Examining Symptom-Specific Effects of Omega-3 Fatty Acids in Children With ADHD / ASD Symptoms and Sleep Problems: A Network Approach.
This study has finished and is no longer accepting participants.
In SwanseaADHDPlacebo researchAges 5–12
CompletedNCT03597789
Tantrum Tamers 2.0: The Role of Emotion
Official study title
The Role of Emotion Regulation and Socialization in Behavioral Parent Training (BPT) Efficiency and Outcomes
This study has finished and is no longer accepting participants.
In Chapel HillADHDBehavioural studyAges 3–8
CompletedNCT05301933
Telehealth BPT in DBP Practice
Official study title
A Pilot Proof of Concept, Multisite, Open Clinical Trial of Telehealth Behavioral Parent Training on Improving Access and Outcomes for Children With ADHD
This study has finished and is no longer accepting participants.
Multiple locations, including New YorkADHDBehavioural studyAges 4–11
CompletedNCT00573859
The Reinforcing Mechanisms of Smoking in Adult ADHD
This study has finished and is no longer accepting participants.
In IrvineADHDMedication studyAges 18–45
CompletedNCT04240756
Treating Parents With ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation study
Official study title
2/2 Treating Mothers With ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial
This study has finished and is no longer accepting participants.
In College ParkADHDMedication studyAges 3–65
CompletedNCT00540826
Treatment Compliance in Children and Adolescents on ADHD Medication
Official study title
Treatment Adherence and Compliance in Children and Adolescents on ADHD Medication and Emotional Expression in Clinical Practice
This study has finished and is no longer accepting participants.
In Bad HomburgADHDObservational studyAges 6–17
CompletedNCT03292848
Study to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Official study title
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHD, BipolarityMedication studyAges 6–12
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.